Friday, September 17

Bayer’s Roundup Settlement Comes Up Short

Bayer AG is scrapping a $1.25 billion proposal for resolving future lawsuits over whether its Roundup weedkiller causes cancer, highlighting the difficulty of settling litigation over a product still on the market.

The snag doesn’t affect deals worth up to $9.6 billion that Bayer reached with lawyers representing tens of thousands of plaintiffs who blame Roundup for making them sick. It does, however, call into question how the German conglomerate will ever fully put to rest the Roundup liabilities it inherited when it purchased…